Prof Alessandra Nicoletti, MD, MSc

Neurology — University of Catania, Italy

LeadR Profile

Prof Alessandra Nicoletti, MD, MSc University of Catania Italy
1 081 ScienceLeadR Reputation 1081
Network Map

Neurology

Subspecialties: Psychiatry - Public Health - Psychology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026

Source: PubMed

University of Catania

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 373

Citations

Citations: 13 203 1st author: 59 Last author: 63 Unique author: 13


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The association between upper limb motor performances and gait dynamics in essential tremor: an emerging relationship.
essential tremor, tremor, gait, walking
J Neural Transm (Vienna)20260
Sleep quality and caregiver burden in Alzheimer's disease: focus on sex differences.
alzheimer disease, caregiver burden, sleep, caregivers, sex characteristics, sex, sleep wake disorders, sex differences
Sleep Med20260
Interlocking pentagons task and visuospatial deficit in parkinsonian syndrome: a quantitative approach.
tauopathies, parkinson disease, parkinsonian disorders, neurology
J Neurol20260
Incidence of Multiple Sclerosis in the City of Catania: A 50-Year Observational Population-Based Study.
sclerosis, multiple sclerosis, incidence, age of onset
Neuroepidemiology20260
Entropy-driven visual choice in Parkinson's disease.
parkinson disease, saccades
Sci Rep20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
An Open Label Extension Multi Centered Phase 2 Trial of TEV 56286 (Emrusolmin) for Multiple System Atrophy
2025-521642-14-00 — safety, atrophy, multiple system atrophy, multiple chronic conditions
Phase 2Recruiting2026

LeadR Networks

Main global connection map